cilostazol and mastoparan

cilostazol has been researched along with mastoparan in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achilleus, D; Bowles, EA; Ellis, CG; Ellsworth, ML; Sprague, RS; Stephenson, AH1

Other Studies

1 other study(ies) available for cilostazol and mastoparan

ArticleYear
A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:6

    Topics: Adenosine Triphosphate; Adult; Animals; Arterioles; Case-Control Studies; Cilostazol; Cricetinae; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Diabetes Mellitus, Type 2; Erythrocytes; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Mesocricetus; Microcirculation; Middle Aged; Missouri; Muscle, Skeletal; Oxygen; Peptides; Phosphodiesterase 3 Inhibitors; Tetrazoles; Vasodilation; Vasodilator Agents; Wasp Venoms; Young Adult

2011